220 related articles for article (PubMed ID: 37516001)
1. Unveiling the therapeutic potential of natural-based anticancer compounds inducing non-canonical cell death mechanisms.
Bozgeyik E; Bozgeyik I
Pathol Res Pract; 2023 Aug; 248():154693. PubMed ID: 37516001
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in natural compounds inducing non-apoptotic cell death for anticancer drug resistance.
Chen JW; Chen S; Chen GQ
Cancer Drug Resist; 2023; 6(4):729-747. PubMed ID: 38239395
[TBL] [Abstract][Full Text] [Related]
3. Non-Canonical Cell Death Induced by p53.
Ranjan A; Iwakuma T
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941671
[TBL] [Abstract][Full Text] [Related]
4. Non-apoptotic cell death-based cancer therapy: Molecular mechanism, pharmacological modulators, and nanomedicine.
Wang X; Hua P; He C; Chen M
Acta Pharm Sin B; 2022 Sep; 12(9):3567-3593. PubMed ID: 36176912
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer.
Zhang C; Liu N
Front Immunol; 2022; 13():920059. PubMed ID: 35958626
[TBL] [Abstract][Full Text] [Related]
6. Non-canonical programmed cell death mechanisms triggered by natural compounds.
Diederich M; Cerella C
Semin Cancer Biol; 2016 Oct; 40-41():4-34. PubMed ID: 27262793
[TBL] [Abstract][Full Text] [Related]
7. Natural Products as Inducers of Non-Canonical Cell Death: A Weapon against Cancer.
Greco G; Catanzaro E; Fimognari C
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33467668
[TBL] [Abstract][Full Text] [Related]
8. Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies.
Liao M; Qin R; Huang W; Zhu HP; Peng F; Han B; Liu B
J Hematol Oncol; 2022 Apr; 15(1):44. PubMed ID: 35414025
[TBL] [Abstract][Full Text] [Related]
9. Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies.
Woo Y; Lee HJ; Jung YM; Jung YJ
Cells; 2020 Dec; 9(12):. PubMed ID: 33348858
[TBL] [Abstract][Full Text] [Related]
10. The therapeutic potential of targeting regulated non-apoptotic cell death.
Hadian K; Stockwell BR
Nat Rev Drug Discov; 2023 Sep; 22(9):723-742. PubMed ID: 37550363
[TBL] [Abstract][Full Text] [Related]
11. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
[TBL] [Abstract][Full Text] [Related]
12. Induction Mechanism of Ferroptosis, Necroptosis, and Pyroptosis: A Novel Therapeutic Target in Nervous System Diseases.
Tang L; Liu S; Li S; Chen Y; Xie B; Zhou J
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373274
[TBL] [Abstract][Full Text] [Related]
13. Ferroptosis, necroptosis, and pyroptosis in cancer: Crucial cell death types in radiotherapy and post-radiotherapy immune activation.
Wang Y; Wang Y; Pan J; Gan L; Xue J
Radiother Oncol; 2023 Jul; 184():109689. PubMed ID: 37150447
[TBL] [Abstract][Full Text] [Related]
14. Targeting of non-apoptotic cancer cell death mechanisms by quercetin: Implications in cancer therapy.
Yang H; Xu S; Tang L; Gong J; Fang H; Wei J; Su D
Front Pharmacol; 2022; 13():1043056. PubMed ID: 36467088
[TBL] [Abstract][Full Text] [Related]
15. Natural Compounds As Modulators of Non-apoptotic Cell Death in Cancer Cells.
Curr Genomics; ; . PubMed ID: 28367073
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
